Rohto Pharmaceutical (4527) · InitiativeAchieved
Lowering the Investment Unit and Broadening the Investor Base Through a Stock Split
First written in FY2023-Q2. 1 of 2 entries say "Achieved", first in FY2023-Q3. Latest entry: FY2023-Q3.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Share SplitA theme 1121 companies write about · 0 as a headwind · 1109 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 1134 threads.Full recordFilings, disclosures and news, newest first
- FY2023-Q3AchievedAnnual report
「Effective 1 January 2023, the number of shares held by shareholders recorded in the shareholder register as of 31 December 2022 was split at a ratio of 2 shares for 1 share.」
The stock split resolved in November 2022 was carried out on 1 January 2023. Each common share was split into 2 shares, completing the measure to improve share liquidity and broaden the investor base by lowering the investment unit. - FY2023-Q2First statedAnnual report
「The purpose is to improve share liquidity and broaden the investor base by reducing the amount per investment unit. With 31 December 2022 as the record date, the Company will conduct a 2-for-1 stock split of its common shares held by shareholders listed or recorded in the final shareholder register on that date.」
The Company resolved to split its common shares 2-for-1, with 31 December 2022 as the record date and 1 January 2023 as the effective date. The purpose is to improve liquidity and broaden the investor base by lowering the investment unit.